Ovarian Cancer Current Events

Ovarian Cancer Current Events, Ovarian Cancer News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 25 | 1000 Results
Common diabetes drug may help treat ovarian cancer
A new study suggests that the common diabetes medication metformin may be considered for use in the prevention or treatment of ovarian cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that ovarian cancer patients who took the drug tended to live longer than patients who did not take it. (2012-12-03)

Yale scientists discover new genetic marker of ovarian cancer risk
A team of Yale researchers have identified a genetic marker that can help predict the risk of developing ovarian cancer, a hard to detect and often deadly form of cancer. (2010-07-20)

Mesothelial cells promote ovarian cancer metastasis
A new study in the Journal of Clinical Investigation indicates that mesothelial cells actively promote the spread of ovarian cancer. (2014-09-09)

Screening for ovarian cancer not recommended
The US Preventive Services Task Force (USPSTF) recommends against screening for ovarian cancer in women without symptoms and who are not known to be at high risk (such as those who have certain hereditary cancer syndromes that increase the risk for ovarian cancer). (2018-02-13)

Changes in ovaries could indicate higher risk of ovarian cancer
Currently, no accurate test for the early detection of ovarian cancer exists. But a new study in the April issue of Gynecologic Oncology suggests that certain cellular and molecular changes in the ovary could provide the warning signs needed for early detection. (2004-04-06)

Study links obesity to elevated risk of ovarian cancer
A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight. (2009-01-05)

Ovarian cancer screening saves few lives
The best currently available screening tests can only slightly reduce ovarian cancer deaths. That is the conclusion of new research published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results suggest that strategies other than screening, such as prevention and better treatments, will be needed to significantly lower the number of women who die from ovarian cancer. (2010-12-13)

Ovarian cancer study offers vital clues for new therapies
Scientists have taken a major step forward in the understanding of ovarian cancer, which could improve treatment for patients with the condition. (2010-04-21)

Ovarian cancer cells hijack surrounding tissues to enhance tumor growth
In this issue of the Journal of Clinical Investigation, researchers at MD Anderson Cancer Center report that ovarian cancer cells activate the HOXA9 gene to compel stromal cells to create an environment that supports tumor growth. (2012-09-04)

1,000 extra ovarian cancer deaths due to HRT in UK since 1991
A suspected 1,000 extra women in the UK have died from ovarian cancer between 1991 and 2005 because they were using Hormone Replacement Therapy, according to an article published online and in an upcoming edition of the Lancet. (2007-04-18)

Aspirin inhibits ovarian cancer growth, lab study finds
Aspirin may inhibit ovarian tumor growth, according to a new laboratory study by the University of South Florida College of Medicine. (2002-11-06)

Removal of ovaries for young women with breast cancer and family history of ovarian cancer
Women diagnosed with breast cancer at a young age who have a family history of either breast or ovarian cancer have a substantially increased risk of developing ovarian cancer compared with women with breast cancer without a family history of either disease, suggest authors of a study published on THE LANCET's website today--(2002-08-27)

Only women with Western Swedish breast cancer gene run higher risk of ovarian cancer
Previous research has shown that women with breast cancer are more likely than other women to develop ovarian cancer, but now researchers from the Sahlgrenska Academy at the University of Gothenburg, Sweden, have shown that actually only women with a known Western Swedish mutation behind hereditary breast cancer run this increased risk of ovarian cancer. (2010-04-03)

VCA fellowship funding to extend ovarian cancer research
Dr. Clare Scott from the Walter and Eliza Hall Institute in Melbourne, Australia, has been awarded a Victorian Cancer Agency (VCA) Clinical Fellowship to further research into an aggressive and highly lethal form of ovarian cancer. (2010-10-26)

The Lancet: Short-term use of hormone replacement therapy associated with increased ovarian cancer risk
Taking hormone replacement therapy for the menopause, even for just a few years, is associated with a significantly increased risk of developing the two most common types of ovarian cancer, according to a detailed re-analysis of all the available evidence, published in The Lancet. (2015-02-12)

Study shows high blood calcium levels may indicate ovarian cancer
A new study from Wake Forest Baptist Medical Center is the first to report that high blood calcium levels might predict of ovarian cancer, the most fatal of the gynecologic cancers. (2013-01-23)

Progestin in oral contraceptives associated with lower risk of ovarian cancer
Oral contraceptives -- better known as birth control pills -- that contain high levels of progestin are associated with a lower risk of ovarian cancer than oral contraceptives with low progestin content, concludes a study in the Jan. 2 issue of the Journal of the National Cancer Institute. (2002-01-01)

Electronic nose detects cancer
György Horvath from the University of Gothenburg, Sweden, and researchers from the University of Gävle and KTH Royal Institute of Technology have been able to confirm in tests that ovarian cancer tissue and healthy tissue smell different. The results were published recently in the journal Future Oncology. (2010-12-20)

Detection of glycoprotein could indentify ovarian and uterine cancers with poor prognosis
The detection of a specific protein molecule could help oncologists identify uterine and ovarian cancers with poor prognosis and thereby enable better disease management of women with aggressive uterine or ovarian cancer, suggest authors of a study in this week's issue of THE LANCET. (2003-09-11)

Study finds multiple markers for breast and ovarian cancer
Scientists from the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR) have made a promising discovery that could improve the early diagnosis of breast and ovarian cancers through a simple blood test. (2005-07-28)

Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR. (2008-04-17)

An artificial ovary for fertility preservation without the risk of reintroducing malignancy
Important steps in the development of an artificial ovary have been successfully completed by one of the world's leading groups in fertility preservation. Researchers from the Rigshospitalet in Copenhagen, Denmark, report today that they have for the first time isolated and grown human follicles to a point of 'biofunctionality' on a bioengineered ovarian scaffold made of 'decellularized' ovarian tissue. The early-stage follicles were isolated from patients having ovarian tissue frozen for fertility preservation ahead of other medical treatments likely to compromise ovarian function. (2018-07-01)

Women without regular medical care at increased risk of ovarian cancer
In this case-control study, Abenhaim and colleagues examined whether the frequency of medical visits and pelvic examinations and the type of health care provider visited had an effect on the risk of ovarian cancer. (2007-03-26)

Medical informatics project targets ovarian, breast cancers
Researchers at Indiana University, Ohio State University and the University of Missouri have begun a five-year, $8 million project that will help doctors better understand the damage caused by breast and ovarian cancers. (2004-10-25)

When cancer runs in the family
5 percent to 10 percent of all breast cancers are monogenic in origin. In other words, there is a mutation of the genes BRCA1, BRCA2 or other high-risk genes. In this edition of Deutsches Ärzteblatt International, Alfons Meindl of the Klinikum rechts der Isar (Munich) and coauthors report on new insights into the pathogenesis and treatment of hereditary breast and ovarian cancer and newly-discovered risk genes. (2011-05-27)

UI Researchers Find Possible Genetic Link Between The X Chromosome And Ovarian Cancer
An imbalance in how genes are expressed on a female's two X chromosomes may lead to the development of ovarian cancer in some women, according to a University of Iowa study. (1999-03-01)

Healthcare professionals need training to help them talk more comfortably about sexual issues
Ovarian cancer affects sexual functioning, but healthcare professionals' knowledge about this is inadequate, as is their communication with patients about sexual issues, concludes a study in this week's BMJ. (2001-10-11)

Early clinical signs of ovarian cancer
Many women diagnosed with ovarian cancer actually complained of symptoms of the disease at least four months before they were diagnosed, according to a new study. (2005-08-22)

Fertility drugs do not increase risk of ovarian cancer
The use of fertility drugs does not increase a woman's risk of developing ovarian cancer, finds a large study from Danish researchers published on bmj.com today. (2009-02-05)

Role of known cancer gene in ovarian cancer investigated
The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia Foundation grant. (2012-02-14)

Biomarkers predict time to ovarian cancer recurrence
In this issue of the Journal of Clinical Investigation, Roel Verchaak and colleagues at the MD Anderson Cancer Center identify protein biomarkers that are predictive for time of ovarian cancer recurrence and develop a PRotein-driven index of OVARian cancer. (2013-08-15)

Discovery by NUS researchers suggests new possibility in treating aggressive ovarian cancer
A study led by Dr Ruby Huang, Principal Investigator at Cancer Science Institute of Singapore at the National University of Singapore, has identified a molecule called AXL which is found to trigger the spread of an aggressive form of ovarian cancer called the Mes subtype. This recent discovery may lead to a new treatment strategy for these patients. (2016-11-29)

Women at risk of ovarian cancer need more guidance from doctors on their choices
Researchers at Cardiff University have found that online information about ovarian cancer can cause as much worry as comfort for women at high risk of developing the disease, in a new study published in ecancer. For women at an increased risk of ovarian cancer but who haven't yet developed the disease, the most effective way to manage their risk is to surgically remove their fallopian tubes and ovaries. (2016-06-30)

COXEN model picks the best drug for ovarian cancer
A University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched. (2014-02-18)

Hormone therapy use associated with increased risk of ovarian cancer
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer, regardless of the duration of use, the formulation, estrogen dose, regimen or route of administration, according to a study in the July 15 issue of JAMA. (2009-07-14)

Sparing ovaries and removing fallopian tubes may cut cancer risk, but few have procedure
During hysterectomies for non-cancerous conditions, removing both fallopian tubes while keeping the ovaries may help protect against ovarian cancer and preserve hormonal levels, but few women receive this surgical option, according to a new study by Yale School of Medicine researchers. (2016-02-01)

New research from Lawson uncovers important molecule in ovarian cancer
Scientists at Lawson Health Research Institute have uncovered an important new target for ovarian cancer therapy. Contrary to current research this new study found that LKB1 is an important molecule in the cancer's promotion and survival. Their research definitively shows that ovarian cancer cells still have LKB1 and that this molecule allows ovarian cancer spheroids to change their metabolism, promote tumor cell survival and make them more resistant to chemotherapy. (2015-07-22)

Multi-Center Study Provides Guidelines For Genetic Testing In Women With Breast Cancer: BRCA Abnormalities Multiply Risk Of Ovarian Cancer
Researchers argue that all women with breast cancer who were diagnosed before age 50 or who have family histories of breast or ovarian cancer should be tested for BRCA1 and BRCA2 mutations, which increase their risk of ovarian cancer 10- fold; nearly 40% of the 238 women studied had mutations. (1998-06-29)

Disarming specialized stem cells might combat deadly ovarian cancer
Eliminating cancer stem cells (CSCs) within a tumor could hold the key to successful treatments for ovarian cancer, which has been notoriously difficult to detect and treat, according to new findings published this week in the journal Oncogene by Yale School of Medicine researchers. (2010-01-27)

A good diet before diagnosis is linked with lower mortality among OVCA survivors
Prediagnosis diet quality was associated with mortality and may have a protective effect after ovarian cancer, according to a new study published Oct. 14 in the JNCI: Journal of the National Cancer Institute. (2014-10-16)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.